10.4 Patient Data Assessment

10.4 Patient Data Assessment

Quick Answer: Patient data assessment is the bridge between raw numbers and clinical decisions. The FPGEE expects you to compute renal function and acid-base parameters, interpret trends and drug-induced lab changes, and apply diagnostic reasoning (sensitivity, specificity, predictive values) to patient cases. Master a small set of formulas cold and you will answer most Domain 4-C items confidently.

Domain 4 of the NABP FPGEE Content Outline devotes 37% of the examination (about 74 questions) to clinical sciences, and sub-domain C — Data assessment — is where quantitative reasoning meets patient care. Three skill clusters are tested: clinical calculations, interpretation of data, and diagnosing. Each is a discrete competency, but on the exam they appear integrated inside case vignettes.

Clinical Calculations

Renal Function Estimation

Creatinine clearance (CrCl) remains the canonical metric for drug dosing because the FDA drug labels are indexed to Cockcroft-Gault. The Cockcroft-Gault equation is:

CrCl (mL/min) = [(140 − age) × weight (kg)] / (72 × SCr) × (0.85 if female)

Use actual body weight if the patient is within 20% of ideal body weight (IBW); otherwise use adjusted body weight (ABW = IBW + 0.4 × [actual − IBW]) in obesity to avoid overestimating renal function. The MDDD and CKD-EPI equations estimate glomerular filtration rate (eGFR) in mL/min/1.73 m² and are not indexed to drug labels — they are used to stage chronic kidney disease (G1 ≥ 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 < 15). When a label says "reduce dose if CrCl < 30 mL/min," use Cockcroft-Gault, not eGFR.

Acid-Base and Electrolyte Corrections

The anion gap (AG = Na − [Cl + HCO3]; normal 8–12 mEq/L) splits metabolic acidosis into high-gap causes (MUDPILES: methanol, uremia, diabetic ketoacidosis, propylene glycol, iron/INH, lactic acidosis, ethylene glycol, salicylates) and normal-gap causes (diarrhea, early renal failure, renal tubular acidosis). Calculate the delta-delta (ΔAG / ΔHCO3; normal 1–2) to detect a mixed disorder: a ratio > 2 suggests a concurrent metabolic alkalosis.

Corrected sodium unmasks true hyponatremia in hyperglycemia: corrected Na = measured Na + 1.6 × (glucose − 100)/100 (some references use 2.4 for glucose > 400). Corrected calcium adjusts for low albumin: corrected Ca = measured Ca + 0.8 × (4.0 − albumin). The osmolal gap (measured − calculated osmolality; normal < 10) screens for toxic alcohols. Fractional excretion of sodium (FENa) = (urine Na × plasma Cr) / (plasma Na × urine Cr) × 100; < 1% suggests prerenal AKI, > 2% intrinsic AKI. The urine anion gap (Na + K − Cl) is negative in diarrhea-induced acidosis (the kidneys excrete NH4+) and positive in distal renal tubular acidosis.

Body Size and Nutrition Metrics

BMI = weight (kg) / height (m)². IBW (Devine): men = 50 kg + 2.3 kg per inch over 5 ft; women = 45.5 kg + 2.3 kg per inch over 5 ft. Adjusted body weight is used for drugs with poor distribution to adipose (vancomycin, aminoglycosides, propofol).

Anticoagulation and Insulin Titration

Warfarin dose adjustments follow the INR: if INR < 4.5 with no bleeding, hold or lower the dose; if 4.5–10 with no bleeding, hold and consider low-dose vitamin K; if > 10 or bleeding, give vitamin K 10 mg IV. Heparin is titrated by aPTT to a goal range (e.g., 60–100 sec) or by anti-Xa levels (0.3–0.7 IU/mL) for low-molecular-weight heparin. Insulin correction scales use (target glucose − current glucose) / correction factor, where correction factor = 1800 / total daily dose (TDD).

ABG Interpretation

Arterial blood gas (ABG) values — pH (7.35–7.45), PaCO2 (35–45 mmHg), PaO2 (80–100 mmHg), HCO3 (22–26 mEq/L), base excess (−2 to +2) — define acid-base disorders. The structured method is: (1) look at pH (acidemia vs alkalemia), (2) look at PaCO2 and HCO3 to determine the primary disturbance, (3) calculate expected compensation (Winter's formula: expected PaCO2 = 1.5 × HCO3 + 8 ± 2 for metabolic acidosis), (4) assess oxygenation.

Interpretation of Data

Trend Analysis

A single value is a snapshot; a trend is the story. Compare today's creatinine to yesterday's and to baseline: a rise of ≥ 0.3 mg/dL in 48 h meets KDIGO criteria for acute kidney injury (AKI). Falling bicarbonate with rising anion gap signals worsening acidosis; rising transaminases greater than 3× the upper limit of normal during statin therapy warrants holding the drug.

Drug-Induced Lab Abnormalities

Common patterns the exam tests: digoxin — digoxin toxicity (nausea, visual disturbances, arrhythmia) at levels > 2 ng/mL, especially with hypokalemia; amiodarone — thyroid dysfunction (both hypo- and hyperthyroidism), transaminitis, pulmonary fibrosis; statins — CK elevation and rare rhabdomyolysis, transaminitis; methotrexate — transaminitis and myelosuppression; trimethoprim — pseudohyperkalemia and elevated serum creatinine (inhibits tubular secretion without lowering GFR); lithium — nephrogenic diabetes insipidus and hypothyroidism.

Therapeutic Drug Monitoring (TDM)

TDM converts a concentration into a dosing decision. Vancomycin is now monitored by AUC/MIC ≥ 400 (trough-only monitoring is being phased out); for serious MRSA infections target AUC 400–600. Aminoglycosides use peak levels (gentamicin 5–10 mg/L for traditional dosing) to confirm efficacy and trough (< 2 mg/L) to limit nephrotoxicity. Phenytoin levels must be corrected for hypoalbuminemia or for uremia: corrected phenytoin = measured / (0.2 × albumin + 0.1).

Culture and Sensitivity

The minimum inhibitory concentration (MIC) is the lowest concentration that inhibits visible growth in vitro. Breakpoints (S, I, R) translate the MIC into a clinical prediction by comparing it to achievable serum concentrations. Always interpret MIC in the context of the infection site (urine vs CSF vs bloodstream): nitrofurantoin has low serum levels but excellent urinary concentrations, so it treats cystitis but not pyelonephritis.

ECG Interpretation Basics

Pharmacists must recognize QTc prolongation (> 470 ms in males, > 480 ms in females) and drugs that cause it (azithromycin, haloperidol, methadone, ondansetron, antipsychotics). A QTc > 500 ms raises the risk of torsades de pointes. Other patterns: narrow-complex tachycardia (SVT), wide-complex tachycardia (VT until proven otherwise), ST elevation (MI).

Diagnosing and Diagnostic Reasoning

Three reasoning modes operate in clinical practice: pattern recognition (instant match to a familiar syndrome — "this is strep throat"), hypothetico-deductive (generate differential, test with data), and algorithmic (follow a protocol, e.g., ADA diabetes screening). Diagnostic test performance is summarized below.

PPV rises when prevalence is high; NPV rises when prevalence is low. This is why screening tests in low-prevalence populations generate many false positives.

Identifying Drug-Related Problems

The standard framework (Cipolle/Strand) classifies drug therapy problems into four domains: indication (need for additional therapy, unnecessary therapy, untreated condition), effectiveness (wrong drug, dose too low), safety (adverse reaction, dose too high), and adherence (non-compliance). Distinguishing drug-induced from disease-induced findings — for example, whether thrombocytopenia in a septic patient is from heparin or from the infection itself — requires integrating the medication history, onset timing, and dechallenge response.

ABG Interpretation Flowchart

              pH < 7.35 (Acidemia)
                    |
        PaCO2 high? ─── HCO3 low?
            |               |
     Respiratory        Metabolic
      acidosis          acidosis
            |               |
  (COPD, hypovent)   (Check anion gap)
                     AG high → MUDPILES
                     AG normal → diarrhea, RTA

              pH > 7.45 (Alkalemia)
                    |
        PaCO2 low? ─── HCO3 high?
            |               |
     Respiratory        Metabolic
      alkalosis          alkalosis
            |               |
 (hyperventilation,   (vomiting, diuretics,
   pain, anxiety)       hyperaldosteronism)

Use this flowchart as a screening tool, then apply Winter's formula (expected PaCO2 = 1.5 × HCO3 + 8 ± 2) to determine whether respiratory compensation is appropriate. If the measured PaCO2 is outside the expected range, a mixed disorder is present.

Core Clinical Calculations for the FPGEE

Memorize the formulas cold: Cockcroft-Gault for drug dosing, CKD-EPI for staging, anion gap and Winter's formula for acid-base, corrected sodium and calcium for electrolyte distortions, FENa for AKI, and osmolar gap for toxic-alcohol screening. The exam typically presents a vignette with labs and asks you to either calculate, interpret, or recommend a dosing change based on the result.